Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Hologic to showcase automated systems for cervical cancer screening at IPV, Berlin

Hologic to showcase automated systems for cervical cancer screening at IPV, Berlin

Differences in lifestyle, tumor genetics linked to head and neck cancer in African Americans

Differences in lifestyle, tumor genetics linked to head and neck cancer in African Americans

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

IUDs may protect from cervical cancer

IUDs may protect from cervical cancer

Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children

Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children

Intrauterine devices may lower risk of cervical cancer among users, study shows

Intrauterine devices may lower risk of cervical cancer among users, study shows

Intrauterine devices may protect against cervical cancer

Intrauterine devices may protect against cervical cancer

Henry Ford study identifies 23 microRNAs for laryngeal cancer

Henry Ford study identifies 23 microRNAs for laryngeal cancer

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

Oncothyreon commences enrollment in PX-866 Phase 2 trial for metastatic castration-resistant prostate cancer

Oncothyreon commences enrollment in PX-866 Phase 2 trial for metastatic castration-resistant prostate cancer

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

Alchemia initiates HA-Irinotecan Phase II clinical study in SCLC

Alchemia initiates HA-Irinotecan Phase II clinical study in SCLC

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

ATA announces five recipients of 2011 thyroid cancer research grants

ATA announces five recipients of 2011 thyroid cancer research grants

BCH joins MD Anderson's Sister Institution network to provide cancer care

BCH joins MD Anderson's Sister Institution network to provide cancer care

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Biologists identify mechanism of H. pylori that damages DNA of gastric mucosal cells

Biologists identify mechanism of H. pylori that damages DNA of gastric mucosal cells

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

Positive topline data from 4SC's resminostat Phase II trial on Hodgkin's Lymphoma

BioAlliance Pharma announces oral communication of Livatag Phase II trial results on liver cancer

BioAlliance Pharma announces oral communication of Livatag Phase II trial results on liver cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.